Copyright
©2012 Baishideng. All rights reserved.
World J Virol. Dec 12, 2012; 1(6): 174-183
Published online Dec 12, 2012. doi: 10.5501/wjv.v1.i6.174
Published online Dec 12, 2012. doi: 10.5501/wjv.v1.i6.174
Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma
Li-Ping Chen, Yan Du, Yi-Fang Han, Tong Su, Hong-Wei Zhang, Guang-Wen Cao, Department of Epidemiology, the Second Military Medical University, Shanghai 200433, China
Jun Zhao, Department of Hepatobiliary Surgery, the Third Affiliated Hospital of the Second Military Medical University, Shanghai 200438, China
Author contributions: Chen LP and Zhao J collected the data from the published literature, drafted the first version and contributed equally to the work; Du Y, Han YF, Su T and Zhang HW critically read the draft; Cao GW presented the study conception, supervised data collection and drafted subsequent versions of this manuscript.
Supported by National Natural Scientific Foundation of China, No. 81025015 and 91129301
Correspondence to: Guang-Wen Cao, MD, PhD, Professor, Chairman, Department of Epidemiology, the Second Military Medical University, 800 Xiangyin Rd., Shanghai 200433, China. gcao@smmu.edu.cn
Telephone: +86-21-81871060 Fax: +86-21-81871060
Received: October 28, 2011
Revised: June 18, 2012
Accepted: November 7, 2012
Published online: December 12, 2012
Revised: June 18, 2012
Accepted: November 7, 2012
Published online: December 12, 2012
Core Tip